Trial Profile
A study to evaluate and compare skin test reactivity of aqueous solutions of Grastek and Ragwitek with commercial extracts
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2016
Price :
$35
*
At a glance
- Drugs Short ragweed pollen allergen extract (Ragwitek) (Primary) ; Timothy grass pollen allergen extract (Grastek) (Primary)
- Indications Allergic rhinitis
- Focus Pharmacodynamics
- 17 Mar 2016 New trial record
- 07 Mar 2016 Results presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology